Skip to main content
logo
Ondine Biomedical Inc. (AIM:OBI)
London flag London · Delayed Price · Currency is GBP · Price in GBX
11.25
-0.25 (-2.17%)
Sep 4, 2026, 4:12 PM GMT

Ondine Biomedical Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
6039362040108
Market Cap Growth
-10.33%9.33%79.20%-50.26%-63.06%-
Enterprise Value
5436351827109
Last Close Price
0.120.090.090.090.200.56

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
41.6727.1131.2627.74101.9672.03
PB Ratio
31.6420.589.3116.015.596.24
P/TBV Ratio
31.6420.589.3116.015.596.24

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
37.8325.2430.8224.9069.7472.76

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.120.120.020.260.120.02
Net Debt / Equity Ratio
-2.91-2.91-1.40-1.17-1.01-1.00
Net Debt / EBITDA Ratio
0.340.340.500.170.631.72
Net Debt / FCF Ratio
0.420.420.620.180.712.35
Asset Turnover
0.200.200.220.110.030.14
Inventory Turnover
0.670.670.620.420.301.80
Quick Ratio
1.021.021.730.953.417.81
Current Ratio
1.231.232.051.363.878.54
Return on Equity (ROE)
-569.72%-569.72%-426.20%-209.95%-93.81%-
Return on Assets (ROA)
-137.70%-137.70%-130.98%-82.98%-46.25%-59.55%
Return on Capital Employed (ROCE)
-835.70%-835.70%-282.70%-659.80%-148.20%-58.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-26.77%-41.15%-29.82%-43.18%-29.78%-27.07%
FCF Yield
-21.73%-33.41%-24.20%-41.44%-25.60%-6.82%
Buyback Yield / Dilution
-69.37%-69.37%-39.31%-1.30%-144.34%-12.69%